471 related articles for article (PubMed ID: 28769537)
1. Osteopontin at the Crossroads of Inflammation and Tumor Progression.
Castello LM; Raineri D; Salmi L; Clemente N; Vaschetto R; Quaglia M; Garzaro M; Gentilli S; Navalesi P; Cantaluppi V; Dianzani U; Aspesi A; Chiocchetti A
Mediators Inflamm; 2017; 2017():4049098. PubMed ID: 28769537
[TBL] [Abstract][Full Text] [Related]
2. Osteopontin as a therapeutic target for cancer.
Bandopadhyay M; Bulbule A; Butti R; Chakraborty G; Ghorpade P; Ghosh P; Gorain M; Kale S; Kumar D; Kumar S; Totakura KV; Roy G; Sharma P; Shetti D; Soundararajan G; Thorat D; Tomar D; Nalukurthi R; Raja R; Mishra R; Yadav AS; Kundu GC
Expert Opin Ther Targets; 2014 Aug; 18(8):883-95. PubMed ID: 24899149
[TBL] [Abstract][Full Text] [Related]
3. Osteopontin shapes immunosuppression in the metastatic niche.
Sangaletti S; Tripodo C; Sandri S; Torselli I; Vitali C; Ratti C; Botti L; Burocchi A; Porcasi R; Tomirotti A; Colombo MP; Chiodoni C
Cancer Res; 2014 Sep; 74(17):4706-19. PubMed ID: 25035397
[TBL] [Abstract][Full Text] [Related]
4. Role of Osteopontin in Liver Diseases.
Wen Y; Jeong S; Xia Q; Kong X
Int J Biol Sci; 2016; 12(9):1121-8. PubMed ID: 27570486
[TBL] [Abstract][Full Text] [Related]
5. Loss of host-derived osteopontin creates a glioblastoma-promoting microenvironment.
Szulzewsky F; Schwendinger N; Güneykaya D; Cimino PJ; Hambardzumyan D; Synowitz M; Holland EC; Kettenmann H
Neuro Oncol; 2018 Feb; 20(3):355-366. PubMed ID: 29016864
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin: regulation in tumor metastasis.
Wai PY; Kuo PC
Cancer Metastasis Rev; 2008 Mar; 27(1):103-18. PubMed ID: 18049863
[TBL] [Abstract][Full Text] [Related]
7. The role of osteopontin expression in melanoma progression.
Kiss T; Ecsedi S; Vizkeleti L; Koroknai V; Emri G; Kovács N; Adany R; Balazs M
Tumour Biol; 2015 Sep; 36(10):7841-7. PubMed ID: 25944164
[TBL] [Abstract][Full Text] [Related]
8. Osteopontin and the skin: multiple emerging roles in cutaneous biology and pathology.
Buback F; Renkl AC; Schulz G; Weiss JM
Exp Dermatol; 2009 Sep; 18(9):750-9. PubMed ID: 19558497
[TBL] [Abstract][Full Text] [Related]
9. Osteopontin and thrombospondin-1 play opposite roles in promoting tumor aggressiveness of primary resected non-small cell lung cancer.
Rouanne M; Adam J; Goubar A; Robin A; Ohana C; Louvet E; Cormier J; Mercier O; Dorfmüller P; Fattal S; de Montpreville VT; Lebret T; Dartevelle P; Fadel E; Besse B; Olaussen KA; Auclair C; Soria JC
BMC Cancer; 2016 Jul; 16():483. PubMed ID: 27422280
[TBL] [Abstract][Full Text] [Related]
10. Pathophysiological role of osteopontin in hepatic inflammation, toxicity, and cancer.
Ramaiah SK; Rittling S
Toxicol Sci; 2008 May; 103(1):4-13. PubMed ID: 17890765
[TBL] [Abstract][Full Text] [Related]
11. Role of the metastasis-promoting protein osteopontin in the tumour microenvironment.
Anborgh PH; Mutrie JC; Tuck AB; Chambers AF
J Cell Mol Med; 2010 Aug; 14(8):2037-44. PubMed ID: 20597997
[TBL] [Abstract][Full Text] [Related]
12. The significance of the co-existence of osteopontin and tumor-associated macrophages in gastric cancer progression.
Lin CN; Wang CJ; Chao YJ; Lai MD; Shan YS
BMC Cancer; 2015 Mar; 15():128. PubMed ID: 25872762
[TBL] [Abstract][Full Text] [Related]
13. Is Osteopontin a Friend or Foe of Cell Apoptosis in Inflammatory Gastrointestinal and Liver Diseases?
Iida T; Wagatsuma K; Hirayama D; Nakase H
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29267211
[TBL] [Abstract][Full Text] [Related]
14. Osteopontin gene expression determines spontaneous metastatic performance of orthotopic human breast cancer xenografts.
Suzuki M; Mose E; Galloy C; Tarin D
Am J Pathol; 2007 Aug; 171(2):682-92. PubMed ID: 17620367
[TBL] [Abstract][Full Text] [Related]
15. Osteopontin: an emerging therapeutic target for anticancer therapy.
Jain S; Chakraborty G; Bulbule A; Kaur R; Kundu GC
Expert Opin Ther Targets; 2007 Jan; 11(1):81-90. PubMed ID: 17150036
[TBL] [Abstract][Full Text] [Related]
16. Tumor microenvironment in diffuse large B-cell lymphoma: Matrixmetalloproteinases activation is mediated by osteopontin overexpression.
Malaponte G; Hafsi S; Polesel J; Castellano G; Spessotto P; Guarneri C; Canevari S; Signorelli SS; McCubrey JA; Libra M
Biochim Biophys Acta; 2016 Mar; 1863(3):483-489. PubMed ID: 26381542
[TBL] [Abstract][Full Text] [Related]
17. The thrombin inhibitor Argatroban reduces breast cancer malignancy and metastasis via osteopontin-dependent and osteopontin-independent mechanisms.
Schulze EB; Hedley BD; Goodale D; Postenka CO; Al-Katib W; Tuck AB; Chambers AF; Allan AL
Breast Cancer Res Treat; 2008 Nov; 112(2):243-54. PubMed ID: 18097747
[TBL] [Abstract][Full Text] [Related]
18. Genetic deletion of osteopontin in TRAMP mice skews prostate carcinogenesis from adenocarcinoma to aggressive human-like neuroendocrine cancers.
Mauri G; Jachetti E; Comuzzi B; Dugo M; Arioli I; Miotti S; Sangaletti S; Di Carlo E; Tripodo C; Colombo MP
Oncotarget; 2016 Jan; 7(4):3905-20. PubMed ID: 26700622
[TBL] [Abstract][Full Text] [Related]
19. Osteopontin knockdown suppresses tumorigenicity of human metastatic breast carcinoma, MDA-MB-435.
Shevde LA; Samant RS; Paik JC; Metge BJ; Chambers AF; Casey G; Frost AR; Welch DR
Clin Exp Metastasis; 2006; 23(2):123-33. PubMed ID: 16830223
[TBL] [Abstract][Full Text] [Related]
20. Osteopontin promotes ovarian cancer progression and cell survival and increases HIF-1alpha expression through the PI3-K/Akt pathway.
Song G; Cai QF; Mao YB; Ming YL; Bao SD; Ouyang GL
Cancer Sci; 2008 Oct; 99(10):1901-7. PubMed ID: 19016748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]